デフォルト表紙
市場調査レポート
商品コード
1318924

単位用量製造市場:製品別(液体単位用量、固体単位用量)、ソーシング別(インハウス、アウトソーシング)、エンドユーザー別-2023-2030年の世界予測

Unit Dose Manufacturing Market by Product (Liquid Unit Dose, Solid Unit Dose), Sourcing (In-House, Outsourcing), End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
単位用量製造市場:製品別(液体単位用量、固体単位用量)、ソーシング別(インハウス、アウトソーシング)、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

単位用量製造の世界市場は、2023年に233億4,000万米ドル、CAGR18.69%で大きく成長し、2030年には778億1,000万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の単位用量製造市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.単位用量製造の世界市場規模および予測は?

2.予測期間中、世界の単位用量製造市場を形成するCOVID-19の阻害要因と影響は?

3.単位用量製造の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.単位用量製造の世界市場における競争戦略は?

5.単位用量製造の世界市場における技術動向と規制の枠組みは?

6.単位用量製造の世界市場における主要ベンダーの市場シェアは?

7.単位用量製造の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 投薬ミスを減らすために単位用量の採用を増やす
      • 再包装よりも単位用量を製造することの利点に対する意識の高まり
      • 製薬業界の急速な発展
    • 抑制要因
      • 原材料価格の変動
    • 機会
      • 革新的な梱包技術と配送ソリューション
      • 固形製剤の連続製造(CM)の採用
    • 課題
      • 製造された単位用量の採用に関連する問題
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 単位用量製造市場:製品別

  • 液体単位用量
  • 固体単位線量

第7章 単位用量製造市場調達別

  • 社内
  • アウトソーシング

第8章 単位用量製造市場:エンドユーザー別

  • 病院
  • 独立系薬局
  • 長期介護施設

第9章 南北アメリカの単位用量製造市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の単位用量製造市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの単位用量製造市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. UNIT DOSE MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. UNIT DOSE MANUFACTURING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. UNIT DOSE MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2022 VS 2030 (%)
  • FIGURE 6. UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. UNIT DOSE MANUFACTURING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. UNIT DOSE MANUFACTURING MARKET DYNAMICS
  • FIGURE 9. UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. UNIT DOSE MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. UNIT DOSE MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. UNIT DOSE MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. UNIT DOSE MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. UNIT DOSE MANUFACTURING MARKET SIZE, BY LIQUID UNIT DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. UNIT DOSE MANUFACTURING MARKET SIZE, BY SOLID UNIT DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 8. UNIT DOSE MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. UNIT DOSE MANUFACTURING MARKET SIZE, BY OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. UNIT DOSE MANUFACTURING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. UNIT DOSE MANUFACTURING MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. UNIT DOSE MANUFACTURING MARKET SIZE, BY LONG TERM CARE FACILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNIT DOSE MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 142. UNIT DOSE MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 143. UNIT DOSE MANUFACTURING MARKET LICENSE & PRICING
目次
Product Code: MRR-3A2E844FE01A

The Global Unit Dose Manufacturing Market is forecasted to grow significantly, with a projected USD 23.34 billion in 2023 at a CAGR of 18.69% and expected to reach a staggering USD 77.81 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Unit Dose Manufacturing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Unit Dose Manufacturing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Liquid Unit Dose and Solid Unit Dose. The Liquid Unit Dose is projected to witness significant market share during forecast period.

Based on Sourcing, market is studied across In-House and Outsourcing. The Outsourcing is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Hospitals, Independent Pharmacies, and Long Term Care Facility. The Long Term Care Facility is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Unit Dose Manufacturing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Unit Dose Manufacturing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Unit Dose Manufacturing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Unit Dose Manufacturing Market?

4. What is the competitive strategic window for opportunities in the Global Unit Dose Manufacturing Market?

5. What are the technology trends and regulatory frameworks in the Global Unit Dose Manufacturing Market?

6. What is the market share of the leading vendors in the Global Unit Dose Manufacturing Market?

7. What modes and strategic moves are considered suitable for entering the Global Unit Dose Manufacturing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Unit Dose Manufacturing Market, by Product, 2022 vs 2030
  • 4.3. Unit Dose Manufacturing Market, by Sourcing, 2022 vs 2030
  • 4.4. Unit Dose Manufacturing Market, by End-User, 2022 vs 2030
  • 4.5. Unit Dose Manufacturing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of unit doses to reduce medication errors
      • 5.1.1.2. Rising awareness of benefits of manufacturing unit doses over repackaging
      • 5.1.1.3. Rapid development in the pharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuations in the prices of raw materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative packaging technologies and delivery solutions
      • 5.1.3.2. Adopting continuous manufacturing (CM) for solid-dose drug products
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with the adoption of manufactured unit doses
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Unit Dose Manufacturing Market, by Product

  • 6.1. Introduction
  • 6.2. Liquid Unit Dose
  • 6.3. Solid Unit Dose

7. Unit Dose Manufacturing Market, by Sourcing

  • 7.1. Introduction
  • 7.2. In-House
  • 7.3. Outsourcing

8. Unit Dose Manufacturing Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Independent Pharmacies
  • 8.4. Long Term Care Facility

9. Americas Unit Dose Manufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Unit Dose Manufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Unit Dose Manufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing